| 07/22/07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/22/06 | Notification about results of final buy-back of shares | AQ |
| 30/21/30 | Notification about final share buy-back | AQ |
| 28/21/28 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/21/28 | On substantial participation (4) - specified | AQ |
| 1 day | +7.19% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 01/09/2022 |
| Director/Board Member | 63 | 19/06/2021 | |
Vadims Telica
BRD | Director/Board Member | 63 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/08/21 | Sell | Chief Financial Officer | 97,424 | 0.6917% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.19% | +2.67% | - | - | 15Cr | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,22400Cr | |
| +1.53% | +2.84% | +47.48% | +89.01% | 66TCr | |
| +1.68% | +1.96% | +29.16% | +109.31% | 51TCr | |
| +0.29% | +3.04% | +53.92% | +66.93% | 39TCr | |
| +3.83% | -0.62% | +69.01% | +42.32% | 36TCr | |
| +0.74% | +4.17% | +34.85% | +57.56% | 30TCr | |
| +3.44% | +4.85% | +7.17% | +31.59% | 27TCr | |
| +1.97% | +3.01% | +57.91% | +76.14% | 25TCr | |
| +4.03% | +5.36% | +39.76% | +116.14% | 21TCr | |
| Average | +2.74% | +2.59% | +45.35% | +81.58% | 46.41TCr | |
| Weighted average by Cap. | +2.18% | +3.04% | +50.66% | +96.45% |
Employees
2,191
Sector
Pharmaceuticals
